Alaunos Therapeutics, Inc. Operating Lease Liability
Alaunos Therapeutics, Inc. (TCRT) had Operating Lease Liability of $2.75 million as of 2022-12-31, per its 10-K filed 2023-03-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2023-03-07
- 2022-12-31: Operating Lease, Liability $2.75M.
- 2021-12-31: Operating Lease, Liability $5.25M.
- 2021-09-30: Operating Lease, Liability $5.42M.
- 2021-06-30: Operating Lease, Liability $5.66M.
| Period end | Operating Lease, Liability |
|---|---|
| 2022-12-31 | $2.75M 10-K · filed 2023-03-07 |
| 2021-12-31 | $5.25M 10-K · filed 2022-03-30 |
| 2021-09-30 | $5.42M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $5.66M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $4.50M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.81M 10-K · filed 2021-03-01 |
| 2020-09-30 | $2.52M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.99M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.19M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.35M 10-K · filed 2020-03-02 |
| 2019-09-30 | $1.32M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.44M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.59M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |